These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37215715)

  • 21. Serum leucine-rich alpha-2 glycoprotein in monitoring disease activity and intestinal mucosal healing for biotherapy-naïve cases with ulcerative colitis.
    Kono M; Komeda Y; Tribonias G; Yoshida S; Nomura K; Handa K; Nagai T; Hagiwara S; Omoto S; Takenaka M; Nishida N; Tsuji N; Kashida H; Kudo M
    JGH Open; 2023 Aug; 7(8):579-583. PubMed ID: 37649867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases.
    Boiardi L; Galli E; Macchioni P; Muratore F; Klinowski G; Hunder GG; Casali M; Besutti G; Spaggiari L; Versari A; Croci S; Mancuso P; Rossi PG; Marvisi C; Salvarani C
    Semin Arthritis Rheum; 2023 Apr; 59():152173. PubMed ID: 36780709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins.
    de Souza AW; van der Geest KS; Brouwer E; Pinheiro FA; Oliveira AC; Sato EI; Andrade LE; Bijl M; Westra J; Kallenberg CG
    Arthritis Res Ther; 2015 Jun; 17(1):158. PubMed ID: 26062541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Appropriate leucine-rich α-2 glycoprotein cut-off value for Japanese patients with ulcerative colitis.
    Yamazato M; Yanai S; Oizumi T; Eizuka M; Yamada S; Toya Y; Uesugi N; Sugai T; Matsumoto T
    World J Clin Cases; 2023 Nov; 11(32):7753-7760. PubMed ID: 38073694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease.
    Yasutomi E; Inokuchi T; Hiraoka S; Takei K; Igawa S; Yamamoto S; Ohmori M; Oka S; Yamasaki Y; Kinugasa H; Takahara M; Harada K; Furukawa M; Itoshima K; Okada K; Otsuka F; Tanaka T; Mitsuhashi T; Kato J; Okada H
    Sci Rep; 2021 May; 11(1):11086. PubMed ID: 34045529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study.
    Saito S; Okuyama A; Okada Y; Shibata A; Sakai R; Kurasawa T; Kondo T; Takei H; Amano K
    Rheumatology (Oxford); 2020 Jul; 59(7):1617-1621. PubMed ID: 31665468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker for Transmural Inflammation in Crohn's Disease.
    Takenaka K; Kitazume Y; Kawamoto A; Fujii T; Udagawa Y; Wanatabe R; Shimizu H; Hibiya S; Nagahori M; Ohtsuka K; Sato H; Hirakawa A; Watanabe M; Okamoto R
    Am J Gastroenterol; 2023 Jun; 118(6):1028-1035. PubMed ID: 36571769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The C-Reactive Protein/Albumin Ratio and Complete Blood Count Parameters as Indicators of Disease Activity in Patients with Takayasu Arteritis.
    Seringec Akkececi N; Yildirim Cetin G; Gogebakan H; Acipayam C
    Med Sci Monit; 2019 Feb; 25():1401-1409. PubMed ID: 30792377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases.
    Serada S; Fujimoto M; Ogata A; Terabe F; Hirano T; Iijima H; Shinzaki S; Nishikawa T; Ohkawara T; Iwahori K; Ohguro N; Kishimoto T; Naka T
    Ann Rheum Dis; 2010 Apr; 69(4):770-4. PubMed ID: 19854709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and differential diagnosis of large-vessel vasculitides.
    Keser G; Aksu K
    Rheumatol Int; 2019 Feb; 39(2):169-185. PubMed ID: 30221327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal Use of Serum Leucine-Rich Alpha-2 Glycoprotein as a Biomarker for Small Bowel Lesions of Crohn's Disease.
    Asonuma K; Kobayashi T; Kikkawa N; Nakano M; Sagami S; Morikubo H; Miyatani Y; Hojo A; Fukuda T; Hibi T
    Inflamm Intest Dis; 2023; 8(1):13-22. PubMed ID: 37404381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum leucine-rich α2-glycoprotein is elevated in patients with systemic lupus erythematosus and correlates with disease activity.
    Ahn SS; Park Y; Jung SM; Song JJ; Park YB; Lee SW
    Clin Chim Acta; 2018 Nov; 486():253-258. PubMed ID: 30118672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term complications, monitoring and interventional treatment of large vessel vasculitis].
    Wipfler-Freißmuth E; Dejaco C; Both M
    Z Rheumatol; 2020 Aug; 79(6):523-531. PubMed ID: 32430565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leucine-rich α2-glycoprotein as the acute-phase reactant to detect systemic juvenile idiopathic arthritis disease activity during anti-interleukin-6 blockade therapy: A case series.
    Shimizu M; Nakagishi Y; Inoue N; Mizuta M; Yachie A
    Mod Rheumatol; 2017 Sep; 27(5):833-837. PubMed ID: 28094589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leucine-Rich Alpha-2-Glycoprotein (LRG-1) as a Potential Kidney Injury Marker in Kidney Transplant Recipients.
    Popova A; Vasiļvolfa A; Rācenis K; Erts R; Šlisere B; Saulīte AJ; Ziedina I; Folkmane I; Čerņevskis H; Kroiča J; Pētersons A; Kuzema V
    Ann Transplant; 2022 Sep; 27():e936751. PubMed ID: 36065144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leucine-rich alpha-2 glycoprotein in the cerebrospinal fluid is a potential inflammatory biomarker for meningitis.
    Chong PF; Sakai Y; Torisu H; Tanaka T; Furuno K; Mizuno Y; Ohga S; Hara T; Kira R
    J Neurol Sci; 2018 Sep; 392():51-55. PubMed ID: 30097155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study.
    Kushimoto K; Ayano M; Nishimura K; Nakano M; Kimoto Y; Mitoma H; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H
    Arthritis Res Ther; 2021 Sep; 23(1):238. PubMed ID: 34517892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal monitoring of circulating immune cell phenotypes in large vessel vasculitis.
    Matsumoto K; Suzuki K; Yoshida H; Magi M; Kaneko Y; Takeuchi T
    Autoimmun Rev; 2022 Oct; 21(10):103160. PubMed ID: 35926769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis.
    Tatsumi Y; Kakimoto K; Hara A; Mizuta N; Numa K; Kinoshita N; Nakazawa K; Koshiba R; Hirata Y; Ota K; Miyazaki T; Nakamura S; Sakagami K; Arimitsu S; Ito H; Nishikawa H
    J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer.
    Furukawa K; Kawamoto K; Eguchi H; Tanemura M; Tanida T; Tomimaru Y; Akita H; Hama N; Wada H; Kobayashi S; Nonaka Y; Takamatsu S; Shinzaki S; Kumada T; Satomura S; Ito T; Serada S; Naka T; Mori M; Doki Y; Miyoshi E; Nagano H
    Pancreas; 2015 Jan; 44(1):93-8. PubMed ID: 25058884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.